Impact of polymorphisms of TLR4/CD14 and TLR3 on acute rejection in kidney transplantation

Transplantation

Volumn 88, Issue 5, 2009, Pages 699-705

  Hwang, Young Hwan ^a   Ro, Han ^b   Choi, Inho ^b   Kim, Hyunsook ^b   Oh, Kook Hwan ^b   Hwang, Jong Ik ^c   Park, Myoung Hee ^b   Kim, Suhnggwon ^b   Yang, Jaeseok ^b,d   Ahn, Curie ^b  

^a Eulji General Hospital   (South Korea)

^b Seoul National University   (South Korea)

^c Korea University College of Medicine   (South Korea)

^d Seoul National University Hospital   (South Korea)

Author keywords

Acute rejection; Kidney transplantation; Polymorphism; Toll like receptor

Indexed keywords

TOLL LIKE RECEPTOR 4; CD14 ANTIGEN; TLR3 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 3;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; ASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GENE FREQUENCY; GENETIC TRANSCRIPTION; GENOTYPE; HUMAN; HUMAN CELL; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR GENE; REPORTER GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL RATE; WILD TYPE; ALLELE; ALLOTRANSPLANTATION; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETICS; GRAFT REJECTION; GRAFT SURVIVAL; METHODOLOGY;

ALLELES; ANTIGENS, CD14; DISEASE-FREE SURVIVAL; FEMALE; GENOTYPE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, GENETIC; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 4; TRANSPLANTATION, HOMOLOGOUS;

EID: 70349565393     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181b2f34a     Document Type: Article

References (34)

1. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003; 21: 335.
2. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004; 4: 499.
3. Kariko K, Ni H, Capodici J, et al. mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem 2004; 279: 12542.
4. Kiechl S, Lorenz E, Reindl M, et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 2002; 347:185.
5. Edfeldt K, Bennet AM, Eriksson P, et al. Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction. Eur Heart J 2004; 25: 1447.
6. Morange PE, Tiret L, Saut N, et al. TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease: The PRIME Study. Eur J Hum Genet 2004; 12: 1041.
7. Fageras Bottcher M, Hmani-Aifa M, Lindstrom A, et al. A TLR4 polymorphism is associated with asthma and reduced lipopolysaccharideinduced interleukin-12(p70) responses in Swedish children. J Allergy Clin Immunol 2004; 114: 561.
8. Yang IA, Barton SJ, Rorke S, et al. Toll-like receptor 4 polymorphism and severity of atopy in asthmatics. Genes Immun 2004; 5: 41.
9. Smit LA, Bongers SI, Ruven HJ, et al. Atopy and new-onset asthma in young Danish farmers and CD 14, TLR2, and TLR4 genetic polymorphisms: A nested case-control, study. Clin Exp Allergy 2007; 37: 1602.
10. Goldstein DR. Toll like receptors and acute allograft rejection. Transpl Immunol 2006; 17: 11.
11. Perico N, Cattaneo D, Sayegh MH, et al. Delayed graft function in kidney transplantation. Lancet 2004; 364: 1814.
12. Obhrai J, Goldstein DR. The role of toll-like receptors in solid organ transplantation. Transplantation 2006; 81: 497.
13. LaRosa DF, Rahman AH, Turka LA. The innate immune system in allograft rejection and tolerance. J Immunol 2007; 178: 7503.
14. Goldstein DR, Tesar BM, Akira S, et al. Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection. J Clin Invest 2003; 111: 1571.
15. McKay D, Shigeoka A, Rubinstein M, et al. Simultaneous deletion of MyD88 and Trif delays major histocompatibility and minor antigen mismatch allograft rejection. Eur J Immunol 2006; 36: 1994.
16. Palmer SM, Burch LH, Davis RD, et al. The role of innate immunity in acute allograft rejection after lung transplantation. Am J Respir Crit Care Med 2003; 168: 628.
17. Ducloux D, Deschamps M, Yannaraki M, et al. Relevance of Toll-like receptor-4 polymorphisms in renal transplantation. Kidney Iit 2005; 67: 2454.
18. Arbour NC, Lorenz E, Schutte BC, et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000; 25:187.
19. Palmer SM, Burch LH, Mir S, et al. Donor polymorphisms in Toll-like receptor-4 influence the development of rejection after renal transplantation. Clin Transplant 2006; 20: 30.
20. Fckete A, Viklkky O, Hubacek JA, et al. Association between heat shock protein 70s and toll-like receptor polymorphisms with long-term renal allograft survival. Transpl Int 2006; 19: 190.
21. Yoon HJ, Choi JY, Kim CO, et al. Lack of Toll-like receptor 4 and 2 polymorphisms in Korean patients with bacteremia. J Korean Med Sci 2006; 21: 979.
22. Hang J, Zhou W, Zhang H, et al. TLR4 Asp299Gly and Thr399Ile polymorphisms are very rare in the Chinese population. / Endotoxin Res 2004; 10: 238.
23. Yoon HJ, Shin JH, Yang SH, et al. Association of the CD14 gene - 159C polymorphism with progression of IgA nephropathy J Med Genet 2003; 40: 104.
24. Kabesch M. A Glitch in the switch? Of endotoxin, CD14, and allergy. Am J Respir Crit Care Med 2006; 174: 365.
25. Arroyo-Espliguero R, Avanzas P, Jeffery S, et al. CD14 and toll-like receptor 4: A link between infection and acute coronary events? Heart 2004; 90: 983.
26. Ueta M, Sotozono C, Inatomi T, et al. Toll-like receptor 3 gene polymorphisms in Japanese patients with Stevens-Johnson syndrome. Br J Ophthalmol 2007; 91: 962.
27. Barrett JC, Fry B, Mailer J, et al. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263.
28. Sundstrom C, Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer 1976; 17: 565.
29. Wolfs TG, Buurman WA, van Schadewijk A, et al. In vivo expression of Toll-like receptor 2 and 4 by renal epithelial cells: IFN-γ and TNF-α mediated up-regulation during inflammation. J Immunol 2002; 168: 1286.
30. Akira S, Takeda K, Kaisho T. Toll-like receptors: Critical proteins linking innate and acquired immunity. Nat Immunol 2001; 2: 675.
31. Chen L, Wang T, Zhou P, et al. TLR engagement prevents transplantation tolerance. Am J Transplant 2006; 6: 2282.
32. LaRosa DF, Stumhofer JS, Gelman AE, et al. T cell expression of MyD88 is required for resistance to Toxoplasma gondii. Proc Natl Acad Sci. USA 2008; 105: 3855.
33. Wu H, Chen G, Wyburn KR, et al. TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest 2007; 117: 2847.
34. Rehli M, Poltorak A, Schwarzfischer L, et al. PU. 1 and interferon consensus sequence-binding protein regulate the myeloid expression of the human Toll-like receptor 4 gene. J Biol Chem 2000; 275: 9773.